Patents by Inventor Nadezda Sokolova

Nadezda Sokolova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
    Publication number: 20230303569
    Abstract: The invention relates to compounds of structural formula 1 wherein A is independently N or C—R3, R1 is selected from (C1 to C6) alkyl, (C2 to C6) alkenyl, (C2 to C6) alkynyl, (C3 to C10) cycloalkyl, (C5 to C10) cycloalkenyl, (C2 to C6) heterocycloalkyl, (C6 to C10) aryl, and (C2 to C9) heteroaryl, wherein each of the said (C1 to C6) alkyl, (C2 to C6) alkenyl, (C2 to C6) alkynyl, (C3 to C10) cycloalkyl, (C5 to C10) cycloalkenyl, (C2 to C9) heterocycloalkyl, (C6 to C10) aryl, and (C2 to C9) heteroaryl is optionally substituted with at least one R4 group, and wherein said (C2 to C9) heteroaryl is C-attached, and R2 is selected from the group consisting of
    Type: Application
    Filed: May 11, 2023
    Publication date: September 28, 2023
    Applicant: Arisan Therapeutics Inc.
    Inventors: Nadezda Sokolova, Kenneth McCormack, Gregory Henkel, Vidyasagar Reddy Gantla, Eric Brown
  • HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
    Publication number: 20220281825
    Abstract: The invention relates to compounds of structural formula I wherein A, D, and E are independently N or C—R3, G, H, and J are independently N or C, K is N or C—H, L is N, N—R3 or C—R3, and A, D, E, G, H, J, K, and L together cannot have more than 4 N, R1 is selected from (C6 to C10) aryl, (C2 to C9) heteroaryl, and 5-indolyl, wherein each of the said (C6 to C10) aryl and (C2 to C9) heteroaryl is substituted with at least one R4a group, and wherein said (C2 to C9) heteroaryl is C-attached, and R2 is selected from the group consisting of
    Type: Application
    Filed: April 21, 2022
    Publication date: September 8, 2022
    Applicant: Arisan Therapeutics Inc.
    Inventors: Kenneth McCormack, Michael Bruno Plewe, Nadezda Sokolova, Gregory Henkel, Eric Brown, Vidyasagar Reddy Gantla, Young-Jun Shin
  • COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
    Publication number: 20220193038
    Abstract: Compounds as exemplified by compound A are useful in the treatment of arenavirus infections and viral infections mediated by arenavirus glycoproteins.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 23, 2022
    Applicant: Arisan Therapeutics Inc.
    Inventors: Eric Brown, Vidyasagar Reddy Gantla, Nadezda Sokolova, Michael Bruno Plewe, Gregory Henkel, Kenneth McCormack
  • ADAMANTANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTION
    Publication number: 20200017514
    Abstract: Compounds of structural Formula I were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus, wherein, R1, R2, R3, X and Y are defined in the specification.
    Type: Application
    Filed: July 12, 2018
    Publication date: January 16, 2020
    Inventors: Michael Plewe, Eric Brown, Vidyasagar Gantla, Gregory Henkel, Kenneth McCormack, Nadezda Sokolova
  • Heterocyclic Compounds for the Treatment of Arenavirus
    Publication number: 20190308938
    Abstract: The invention relates to compounds of structural formula I wherein A, D, and E are independently N or C—R3, G, H, and J are independently N or C, K is N or C—H, L is N, N—R3 or C—R3, and A, D, E, G, H, J, K, and L together cannot have more than 4 N, R1 is selected from (C6 to C10) aryl, (C2 to C9) heteroaryl, and 5-indolyl, wherein each of the said (C6 to C10) aryl and (C2 to C9) heteroaryl is substituted with at least one R4a group, and wherein said (C2 to C9) heteroaryl is C-attached, and R2 is selected from the group consisting of
    Type: Application
    Filed: July 7, 2017
    Publication date: October 10, 2019
    Inventors: Kenneth McCormack, Michael Bruno Plewe, Nadezda Sokolova, Gregory Henkel, Eric Brown, Vidyasagar Reddy Gantla, Young-Jun Shin